These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 19241839)

  • 1. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 2. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
    Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
    Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor immunology at the service of cancer immunotherapy.
    Finn OJ
    Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent studies on tumor immunity and prospects for therapy of neoplasms].
    Aoki Y; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):863-71. PubMed ID: 7594896
    [No Abstract]   [Full Text] [Related]  

  • 8. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
    Sensi M; Anichini A
    Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to tumour immunology.
    Keith J
    Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
    [No Abstract]   [Full Text] [Related]  

  • 10. Analyses and perspectives in cancer immunotherapy.
    Nguyen van Binh P; Duc HT
    Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology and physiopathology of the immune system: initiation and termination of immune responses].
    Andris F; Moser M
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):389-94. PubMed ID: 10992889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune escape of tumors: apoptosis resistance and tumor counterattack.
    Igney FH; Krammer PH
    J Leukoc Biol; 2002 Jun; 71(6):907-20. PubMed ID: 12050175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of human tumor antigens recognized by T cells].
    Kawakami Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():562-7. PubMed ID: 15861711
    [No Abstract]   [Full Text] [Related]  

  • 17. The immune system and cancer.
    Loose D; Van de Wiele C
    Cancer Biother Radiopharm; 2009 Jun; 24(3):369-76. PubMed ID: 19538060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 and killer T cells.
    Sticklin LA
    Am J Nurs; 1987 Apr; 87(4):468-9. PubMed ID: 3494403
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
    Spreafico F; Mantovani A
    Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
    [No Abstract]   [Full Text] [Related]  

  • 20. [A scientist's day-dream or future reality? Specific immunotherapy against cancer].
    Kiessling R; Kärre K
    Lakartidningen; 1997 Apr; 94(17):1595-600. PubMed ID: 9182159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.